Skip to main content
. 2013 Jan 21;19(3):366–374. doi: 10.3748/wjg.v19.i3.366

Figure 2.

Figure 2

Overall survival curves of surgical resection and transarterial chemoembolization in patients with liver cirrhosis. Among patients with cirrhosis, the overall survival (OS) rates were not different between the surgical resection group and the transarterial chemoembolization (TACE) group (25.5% vs 24.7% 5-year OS rate, P = 0.225).